An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.

Summary

The purpose of this study is to evaluate the efficacy and safety of two fixed doses (16mg/day and 24mg/day) of galantamine (a drug for treating dementia) versus placebo for the treatment of patients with Alzheimer's disease, and to investigate the dose-response.

Timeline

Start

2001-04

Primary completion

—

Completion

2004-02

Drugs

Indications